Skip to content
No picture yet

Daurismo 25 mg – DIN 02498472

Daurismo is Glasdegib Maleate 25 mg (tablet), sold in Canada. It is used for acute myeloid leukemia. It is supplied by Pfizer Canada ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Glasdegib Maleate 25 mg

Brand
Daurismo
Strength
25 mg
Used for
Acute myeloid leukemia
Form
Tablet
Manufacturer
Pfizer Canada ULC
Drug class
Hedgehog pathway inhibitor
Sold in
Canada
DIN
02498472

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Glasdegib pills and guides

What is Glasdegib used for?

Glasdegib is used for acute myeloid leukemia.

Medicine type
Hedgehog pathway inhibitor
Official uses from the US prescribing label

DAURISMO is indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are ≥75 years old or who have comorbidities that preclude use of intensive induction chemotherapy.

From the FDA-approved label on DailyMed (published Dec 12, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02498472.
  • It names Daurismo, Glasdegib Maleate 25 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Daurismo by Pfizer Canada ULC.

In Canada: prescription only.

Ingredients

Active: Glasdegib (Glasdegib Maleate)

Other Glasdegib pills